Article Versions Notes

Ghasemzad M, Hashemi M, Lavasani ZM, Hossein-khannazer N, Bakhshandeh H, Gramignoli R, Keshavarz Alikhani H, Najimi M, Nikeghbalian S, Vosough M. Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders. Bioengineering. 2022; 9(8):392. https://doi.org/10.3390/bioengineering9080392

Ghasemzad, Mahsa, Mahdieh Hashemi, Zohre Miri Lavasani, Nikoo Hossein-khannazer, Haleh Bakhshandeh, Roberto Gramignoli, Hani Keshavarz Alikhani, Mustapha Najimi, Saman Nikeghbalian, and Massoud Vosough. 2022. "Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders" Bioengineering 9, no. 8: 392. https://doi.org/10.3390/bioengineering9080392

Ghasemzad, M., Hashemi, M., Lavasani, Z. M., Hossein-khannazer, N., Bakhshandeh, H., Gramignoli, R., Keshavarz Alikhani, H., Najimi, M., Nikeghbalian, S., & Vosough, M. (2022). Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders. Bioengineering, 9(8), 392. https://doi.org/10.3390/bioengineering9080392